Mission
Through data-driven precision medicine, we expand possibilities in drug discovery and diagnostics.
Oncocross aims to expand new possibilities in drug discovery and diagnostics through data-driven precision medicine.
Based on our AI platform, multi-omics, and clinical linkage capabilities, we provide interpretations and solutions that are truly useful for decision-making.
OUR VISION
Precision medicine created by Oncocross
By combining clinical experience from the medical field with cutting-edge artificial intelligence technology,
we will become an innovative partner that minimizes uncertainty and maximizes the probability of success throughout the entire drug development cycle.
-
Data-Driven
By integrating and analyzing millions of transcriptomic and clinical datasets, we provide objective, scientific insights that go beyond intuition and experience.
-
Precision Medicine
We lead personalized medicine by identifying optimal targets that reflect each patient's genetic and molecular characteristics, enhancing treatment efficacy while reducing side effects.
-
End-to-End
From new indication and biomarker discovery to diagnosis of cancers of unknown primary, we support integrated AI solutions that span the full cycle of drug discovery and diagnostics.
-
Partnership
Through close open innovation with global pharmaceutical companies, medical institutions, and research institutes, we rapidly commercialize research outcomes and drive innovation in the healthcare industry.
Together with Oncocross, we create new opportunities in drug discovery, diagnostics,
and data-driven expansion.
Let's Build the Next Possibility in Precision Medicine